0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peripheral Drug Eluting Stent Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-12U19166
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Peripheral Drug Eluting Stent Market Research Report 2025
BUY CHAPTERS

Global Peripheral Drug Eluting Stent Market Research Report 2025

Code: QYRE-Auto-12U19166
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peripheral Drug Eluting Stent Market Size

The global market for Peripheral Drug Eluting Stent was valued at US$ 5710 million in the year 2024 and is projected to reach a revised size of US$ 9412 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Peripheral Drug Eluting Stent Market

Peripheral Drug Eluting Stent Market

Peripheral Drug Eluting Stent is a kind of medical device used to treat peripheral vascular stenosis or occlusive disease. It consists of a stent, usually made of metal, and a drug coating. The stent is inserted by balloon expansion or self-expansion to support narrow or blocked blood vessels and keep blood flow open. The drug coating is coated on the surface of the stent and contains drugs that inhibit the proliferation of vascular smooth muscle cells, such as paclitaxel or sirolimus, etc., which can be released slowly after stent implantation, reducing the risk of restenosis and thrombosis in the stent, and improving the long-term patency rate of blood vessels.
North American market for Peripheral Drug Eluting Stent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peripheral Drug Eluting Stent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peripheral Drug Eluting Stent include Boston Scientific, Medtronic, Abbot, W. L. Gore & Associates, iVascular SLU, Meril Life Sciences, Stentys SA, Cordis, Cook Medical, MicroPort Endovascular MedTech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peripheral Drug Eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Drug Eluting Stent.
The Peripheral Drug Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Drug Eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Drug Eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peripheral Drug Eluting Stent Market Report

Report Metric Details
Report Name Peripheral Drug Eluting Stent Market
Accounted market size in year US$ 5710 million
Forecasted market size in 2031 US$ 9412 million
CAGR 7.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific, Medtronic, Abbot, W. L. Gore & Associates, iVascular SLU, Meril Life Sciences, Stentys SA, Cordis, Cook Medical, MicroPort Endovascular MedTech, Advanced Medical Technologies, LifeTech Scientific Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peripheral Drug Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peripheral Drug Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Peripheral Drug Eluting Stent Market growing?

Ans: The Peripheral Drug Eluting Stent Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the Peripheral Drug Eluting Stent Market size in 2031?

Ans: The Peripheral Drug Eluting Stent Market size in 2031 will be US$ 9412 million.

Who are the main players in the Peripheral Drug Eluting Stent Market report?

Ans: The main players in the Peripheral Drug Eluting Stent Market are Boston Scientific, Medtronic, Abbot, W. L. Gore & Associates, iVascular SLU, Meril Life Sciences, Stentys SA, Cordis, Cook Medical, MicroPort Endovascular MedTech, Advanced Medical Technologies, LifeTech Scientific Corporation

What are the Application segmentation covered in the Peripheral Drug Eluting Stent Market report?

Ans: The Applications covered in the Peripheral Drug Eluting Stent Market report are Hospitals, Mobile Surgery Center, Others

What are the Type segmentation covered in the Peripheral Drug Eluting Stent Market report?

Ans: The Types covered in the Peripheral Drug Eluting Stent Market report are Metal Alloy Stent, Biodegradable Stent

Recommended Reports

Peripheral Vascular Devices

Stents & Implantables

Drug Eluting Technologies

1 Peripheral Drug Eluting Stent Market Overview
1.1 Product Definition
1.2 Peripheral Drug Eluting Stent by Type
1.2.1 Global Peripheral Drug Eluting Stent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metal Alloy Stent
1.2.3 Biodegradable Stent
1.3 Peripheral Drug Eluting Stent by Application
1.3.1 Global Peripheral Drug Eluting Stent Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Mobile Surgery Center
1.3.4 Others
1.4 Global Peripheral Drug Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Peripheral Drug Eluting Stent Revenue 2020-2031
1.4.2 Global Peripheral Drug Eluting Stent Sales 2020-2031
1.4.3 Global Peripheral Drug Eluting Stent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peripheral Drug Eluting Stent Market Competition by Manufacturers
2.1 Global Peripheral Drug Eluting Stent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peripheral Drug Eluting Stent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peripheral Drug Eluting Stent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peripheral Drug Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Drug Eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Drug Eluting Stent, Product Type & Application
2.7 Global Key Manufacturers of Peripheral Drug Eluting Stent, Date of Enter into This Industry
2.8 Global Peripheral Drug Eluting Stent Market Competitive Situation and Trends
2.8.1 Global Peripheral Drug Eluting Stent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peripheral Drug Eluting Stent Players Market Share by Revenue
2.8.3 Global Peripheral Drug Eluting Stent Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peripheral Drug Eluting Stent Market Scenario by Region
3.1 Global Peripheral Drug Eluting Stent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peripheral Drug Eluting Stent Sales by Region: 2020-2031
3.2.1 Global Peripheral Drug Eluting Stent Sales by Region: 2020-2025
3.2.2 Global Peripheral Drug Eluting Stent Sales by Region: 2026-2031
3.3 Global Peripheral Drug Eluting Stent Revenue by Region: 2020-2031
3.3.1 Global Peripheral Drug Eluting Stent Revenue by Region: 2020-2025
3.3.2 Global Peripheral Drug Eluting Stent Revenue by Region: 2026-2031
3.4 North America Peripheral Drug Eluting Stent Market Facts & Figures by Country
3.4.1 North America Peripheral Drug Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peripheral Drug Eluting Stent Sales by Country (2020-2031)
3.4.3 North America Peripheral Drug Eluting Stent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Drug Eluting Stent Market Facts & Figures by Country
3.5.1 Europe Peripheral Drug Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peripheral Drug Eluting Stent Sales by Country (2020-2031)
3.5.3 Europe Peripheral Drug Eluting Stent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Drug Eluting Stent Market Facts & Figures by Region
3.6.1 Asia Pacific Peripheral Drug Eluting Stent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peripheral Drug Eluting Stent Sales by Region (2020-2031)
3.6.3 Asia Pacific Peripheral Drug Eluting Stent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Peripheral Drug Eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Peripheral Drug Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peripheral Drug Eluting Stent Sales by Country (2020-2031)
3.7.3 Latin America Peripheral Drug Eluting Stent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peripheral Drug Eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Drug Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peripheral Drug Eluting Stent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peripheral Drug Eluting Stent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peripheral Drug Eluting Stent Sales by Type (2020-2031)
4.1.1 Global Peripheral Drug Eluting Stent Sales by Type (2020-2025)
4.1.2 Global Peripheral Drug Eluting Stent Sales by Type (2026-2031)
4.1.3 Global Peripheral Drug Eluting Stent Sales Market Share by Type (2020-2031)
4.2 Global Peripheral Drug Eluting Stent Revenue by Type (2020-2031)
4.2.1 Global Peripheral Drug Eluting Stent Revenue by Type (2020-2025)
4.2.2 Global Peripheral Drug Eluting Stent Revenue by Type (2026-2031)
4.2.3 Global Peripheral Drug Eluting Stent Revenue Market Share by Type (2020-2031)
4.3 Global Peripheral Drug Eluting Stent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peripheral Drug Eluting Stent Sales by Application (2020-2031)
5.1.1 Global Peripheral Drug Eluting Stent Sales by Application (2020-2025)
5.1.2 Global Peripheral Drug Eluting Stent Sales by Application (2026-2031)
5.1.3 Global Peripheral Drug Eluting Stent Sales Market Share by Application (2020-2031)
5.2 Global Peripheral Drug Eluting Stent Revenue by Application (2020-2031)
5.2.1 Global Peripheral Drug Eluting Stent Revenue by Application (2020-2025)
5.2.2 Global Peripheral Drug Eluting Stent Revenue by Application (2026-2031)
5.2.3 Global Peripheral Drug Eluting Stent Revenue Market Share by Application (2020-2031)
5.3 Global Peripheral Drug Eluting Stent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boston Scientific Peripheral Drug Eluting Stent Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Peripheral Drug Eluting Stent Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbot
6.3.1 Abbot Company Information
6.3.2 Abbot Description and Business Overview
6.3.3 Abbot Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbot Peripheral Drug Eluting Stent Product Portfolio
6.3.5 Abbot Recent Developments/Updates
6.4 W. L. Gore & Associates
6.4.1 W. L. Gore & Associates Company Information
6.4.2 W. L. Gore & Associates Description and Business Overview
6.4.3 W. L. Gore & Associates Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 W. L. Gore & Associates Peripheral Drug Eluting Stent Product Portfolio
6.4.5 W. L. Gore & Associates Recent Developments/Updates
6.5 iVascular SLU
6.5.1 iVascular SLU Company Information
6.5.2 iVascular SLU Description and Business Overview
6.5.3 iVascular SLU Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 iVascular SLU Peripheral Drug Eluting Stent Product Portfolio
6.5.5 iVascular SLU Recent Developments/Updates
6.6 Meril Life Sciences
6.6.1 Meril Life Sciences Company Information
6.6.2 Meril Life Sciences Description and Business Overview
6.6.3 Meril Life Sciences Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Meril Life Sciences Peripheral Drug Eluting Stent Product Portfolio
6.6.5 Meril Life Sciences Recent Developments/Updates
6.7 Stentys SA
6.7.1 Stentys SA Company Information
6.7.2 Stentys SA Description and Business Overview
6.7.3 Stentys SA Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Stentys SA Peripheral Drug Eluting Stent Product Portfolio
6.7.5 Stentys SA Recent Developments/Updates
6.8 Cordis
6.8.1 Cordis Company Information
6.8.2 Cordis Description and Business Overview
6.8.3 Cordis Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cordis Peripheral Drug Eluting Stent Product Portfolio
6.8.5 Cordis Recent Developments/Updates
6.9 Cook Medical
6.9.1 Cook Medical Company Information
6.9.2 Cook Medical Description and Business Overview
6.9.3 Cook Medical Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cook Medical Peripheral Drug Eluting Stent Product Portfolio
6.9.5 Cook Medical Recent Developments/Updates
6.10 MicroPort Endovascular MedTech
6.10.1 MicroPort Endovascular MedTech Company Information
6.10.2 MicroPort Endovascular MedTech Description and Business Overview
6.10.3 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product Portfolio
6.10.5 MicroPort Endovascular MedTech Recent Developments/Updates
6.11 Advanced Medical Technologies
6.11.1 Advanced Medical Technologies Company Information
6.11.2 Advanced Medical Technologies Description and Business Overview
6.11.3 Advanced Medical Technologies Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Advanced Medical Technologies Peripheral Drug Eluting Stent Product Portfolio
6.11.5 Advanced Medical Technologies Recent Developments/Updates
6.12 LifeTech Scientific Corporation
6.12.1 LifeTech Scientific Corporation Company Information
6.12.2 LifeTech Scientific Corporation Description and Business Overview
6.12.3 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product Portfolio
6.12.5 LifeTech Scientific Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Drug Eluting Stent Industry Chain Analysis
7.2 Peripheral Drug Eluting Stent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Drug Eluting Stent Production Mode & Process Analysis
7.4 Peripheral Drug Eluting Stent Sales and Marketing
7.4.1 Peripheral Drug Eluting Stent Sales Channels
7.4.2 Peripheral Drug Eluting Stent Distributors
7.5 Peripheral Drug Eluting Stent Customer Analysis
8 Peripheral Drug Eluting Stent Market Dynamics
8.1 Peripheral Drug Eluting Stent Industry Trends
8.2 Peripheral Drug Eluting Stent Market Drivers
8.3 Peripheral Drug Eluting Stent Market Challenges
8.4 Peripheral Drug Eluting Stent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Peripheral Drug Eluting Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peripheral Drug Eluting Stent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peripheral Drug Eluting Stent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peripheral Drug Eluting Stent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Peripheral Drug Eluting Stent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peripheral Drug Eluting Stent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peripheral Drug Eluting Stent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peripheral Drug Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peripheral Drug Eluting Stent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peripheral Drug Eluting Stent, Product Type & Application
 Table 12. Global Key Manufacturers of Peripheral Drug Eluting Stent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peripheral Drug Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug Eluting Stent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peripheral Drug Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2020-2025)
 Table 19. Global Peripheral Drug Eluting Stent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Peripheral Drug Eluting Stent Sales Market Share by Region (2026-2031)
 Table 21. Global Peripheral Drug Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2020-2025)
 Table 23. Global Peripheral Drug Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peripheral Drug Eluting Stent Revenue Market Share by Region (2026-2031)
 Table 25. North America Peripheral Drug Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Peripheral Drug Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Peripheral Drug Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peripheral Drug Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peripheral Drug Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Peripheral Drug Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Peripheral Drug Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peripheral Drug Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peripheral Drug Eluting Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peripheral Drug Eluting Stent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Peripheral Drug Eluting Stent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Peripheral Drug Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peripheral Drug Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peripheral Drug Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Peripheral Drug Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Peripheral Drug Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peripheral Drug Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peripheral Drug Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peripheral Drug Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Peripheral Drug Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Peripheral Drug Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peripheral Drug Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peripheral Drug Eluting Stent Sales (K Units) by Type (2020-2025)
 Table 51. Global Peripheral Drug Eluting Stent Sales (K Units) by Type (2026-2031)
 Table 52. Global Peripheral Drug Eluting Stent Sales Market Share by Type (2020-2025)
 Table 53. Global Peripheral Drug Eluting Stent Sales Market Share by Type (2026-2031)
 Table 54. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peripheral Drug Eluting Stent Revenue Market Share by Type (2020-2025)
 Table 57. Global Peripheral Drug Eluting Stent Revenue Market Share by Type (2026-2031)
 Table 58. Global Peripheral Drug Eluting Stent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Peripheral Drug Eluting Stent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Peripheral Drug Eluting Stent Sales (K Units) by Application (2020-2025)
 Table 61. Global Peripheral Drug Eluting Stent Sales (K Units) by Application (2026-2031)
 Table 62. Global Peripheral Drug Eluting Stent Sales Market Share by Application (2020-2025)
 Table 63. Global Peripheral Drug Eluting Stent Sales Market Share by Application (2026-2031)
 Table 64. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peripheral Drug Eluting Stent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peripheral Drug Eluting Stent Revenue Market Share by Application (2020-2025)
 Table 67. Global Peripheral Drug Eluting Stent Revenue Market Share by Application (2026-2031)
 Table 68. Global Peripheral Drug Eluting Stent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Peripheral Drug Eluting Stent Price (US$/Unit) by Application (2026-2031)
 Table 70. Boston Scientific Company Information
 Table 71. Boston Scientific Description and Business Overview
 Table 72. Boston Scientific Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boston Scientific Peripheral Drug Eluting Stent Product
 Table 74. Boston Scientific Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Peripheral Drug Eluting Stent Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Abbot Company Information
 Table 81. Abbot Description and Business Overview
 Table 82. Abbot Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbot Peripheral Drug Eluting Stent Product
 Table 84. Abbot Recent Developments/Updates
 Table 85. W. L. Gore & Associates Company Information
 Table 86. W. L. Gore & Associates Description and Business Overview
 Table 87. W. L. Gore & Associates Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. W. L. Gore & Associates Peripheral Drug Eluting Stent Product
 Table 89. W. L. Gore & Associates Recent Developments/Updates
 Table 90. iVascular SLU Company Information
 Table 91. iVascular SLU Description and Business Overview
 Table 92. iVascular SLU Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. iVascular SLU Peripheral Drug Eluting Stent Product
 Table 94. iVascular SLU Recent Developments/Updates
 Table 95. Meril Life Sciences Company Information
 Table 96. Meril Life Sciences Description and Business Overview
 Table 97. Meril Life Sciences Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Meril Life Sciences Peripheral Drug Eluting Stent Product
 Table 99. Meril Life Sciences Recent Developments/Updates
 Table 100. Stentys SA Company Information
 Table 101. Stentys SA Description and Business Overview
 Table 102. Stentys SA Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Stentys SA Peripheral Drug Eluting Stent Product
 Table 104. Stentys SA Recent Developments/Updates
 Table 105. Cordis Company Information
 Table 106. Cordis Description and Business Overview
 Table 107. Cordis Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cordis Peripheral Drug Eluting Stent Product
 Table 109. Cordis Recent Developments/Updates
 Table 110. Cook Medical Company Information
 Table 111. Cook Medical Description and Business Overview
 Table 112. Cook Medical Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cook Medical Peripheral Drug Eluting Stent Product
 Table 114. Cook Medical Recent Developments/Updates
 Table 115. MicroPort Endovascular MedTech Company Information
 Table 116. MicroPort Endovascular MedTech Description and Business Overview
 Table 117. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. MicroPort Endovascular MedTech Peripheral Drug Eluting Stent Product
 Table 119. MicroPort Endovascular MedTech Recent Developments/Updates
 Table 120. Advanced Medical Technologies Company Information
 Table 121. Advanced Medical Technologies Description and Business Overview
 Table 122. Advanced Medical Technologies Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Advanced Medical Technologies Peripheral Drug Eluting Stent Product
 Table 124. Advanced Medical Technologies Recent Developments/Updates
 Table 125. LifeTech Scientific Corporation Company Information
 Table 126. LifeTech Scientific Corporation Description and Business Overview
 Table 127. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. LifeTech Scientific Corporation Peripheral Drug Eluting Stent Product
 Table 129. LifeTech Scientific Corporation Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Peripheral Drug Eluting Stent Distributors List
 Table 133. Peripheral Drug Eluting Stent Customers List
 Table 134. Peripheral Drug Eluting Stent Market Trends
 Table 135. Peripheral Drug Eluting Stent Market Drivers
 Table 136. Peripheral Drug Eluting Stent Market Challenges
 Table 137. Peripheral Drug Eluting Stent Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peripheral Drug Eluting Stent
 Figure 2. Global Peripheral Drug Eluting Stent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peripheral Drug Eluting Stent Market Share by Type: 2024 & 2031
 Figure 4. Metal Alloy Stent Product Picture
 Figure 5. Biodegradable Stent Product Picture
 Figure 6. Global Peripheral Drug Eluting Stent Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peripheral Drug Eluting Stent Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Mobile Surgery Center
 Figure 10. Others
 Figure 11. Global Peripheral Drug Eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Peripheral Drug Eluting Stent Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Peripheral Drug Eluting Stent Sales (2020-2031) & (K Units)
 Figure 14. Global Peripheral Drug Eluting Stent Average Price (US$/Unit) & (2020-2031)
 Figure 15. Peripheral Drug Eluting Stent Report Years Considered
 Figure 16. Peripheral Drug Eluting Stent Sales Share by Manufacturers in 2024
 Figure 17. Global Peripheral Drug Eluting Stent Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Peripheral Drug Eluting Stent Players: Market Share by Revenue in Peripheral Drug Eluting Stent in 2024
 Figure 19. Peripheral Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Peripheral Drug Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Peripheral Drug Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 22. North America Peripheral Drug Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 23. United States Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Peripheral Drug Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 26. Europe Peripheral Drug Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Peripheral Drug Eluting Stent Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Peripheral Drug Eluting Stent Revenue Market Share by Region (2020-2031)
 Figure 34. China Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Peripheral Drug Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Peripheral Drug Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Peripheral Drug Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Peripheral Drug Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Peripheral Drug Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Peripheral Drug Eluting Stent by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Peripheral Drug Eluting Stent by Type (2020-2031)
 Figure 54. Global Peripheral Drug Eluting Stent Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Peripheral Drug Eluting Stent by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Peripheral Drug Eluting Stent by Application (2020-2031)
 Figure 57. Global Peripheral Drug Eluting Stent Price (US$/Unit) by Application (2020-2031)
 Figure 58. Peripheral Drug Eluting Stent Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona